期刊文献+

糖耐量减低者的冠状动脉病变特点及相关因素分析 被引量:3

Analysis of the characteristics of coronary pathological changes and its related factors in patients with impaired glucose tolerance
原文传递
导出
摘要 目的研究糖耐量减低(IGT)者的冠状动脉病变特点。方法根据糖耐量(OGTr)结果将疑似缺血性胸痛的住院患者490例分为IGT组(161例)、2型糖尿病(T2DM)组(159例)、糖耐量正常(NGT)组(170例),检测3组血清甘油三酯(TG)、总胆固醇(TC)、高密度脂蛋白胆固醇(HDL-C)、低密度脂蛋白胆固醇(LDL-C)和高敏c反应蛋白(hs—CRP)含量,计算BMI,记录一般临床资料(包括性别、年龄、吸烟史、高血压病史),分析3组的冠状动脉造影(CAG)结果和冠状动脉Gensini评分情况。结果(1)T2DM组、IGT组血清TG[(2.41±1.70)mmol/L和(2.26±1.20)mmol/L]均明显高于NGT组[(1.95±1.14)mmo]/L],差异有统计学意义(t=0.4610,0.3124,P〈0.01,〈0.05),但IGT组和T2DM组间TG水平比较差异无统计学意义(P〉0.05);3组间TC、HDL-C、LDL—C差异无统计学意义(P均〉0.05)。(2)T2DM组和IGT组血清hs—CRP[(2.38±1.76)mg/L和(2.33±2.03)mg/L]均明显高于NGT组[(1.54±1.32)mg/L,t=0.8391,0.7815,P均〈0.01],而T2DM组与IGT组比较差异无统计学意义(P〉0.05)。(3)IGT组和T2DM组的BMI[(25.50±3.04)kg/m^2和(26.09±2.86)kg/m^2]均明显高于NGT组[(24.70±3.27)kg/m^2],差异均有统计学意义(t:0.8063,1.3947,P〈0.05,〈0.01),但T2DM组与IGT组比较差异无统计学意义(P〉0.05)。(4)单支冠状动脉病变发生率NGT组为44.7%,明显高于IGT组(23.6%)和T2DM组(18.9%)(X^2=16.310,25.116,P均〈0.05),但IGT组和T2DM组间差异无统计学意义(P〉0.05);T2DM组、IGT组2支血管病变发生率分别为37.1%和39.8%,均明显高于NGT组(23.5%)(X^2=7.200,10.099,P均〈0.05),而IGT组和T2DM组间差异无统计学意义(P〉0.05);3支冠状动脉病变发生率IGT组和T2DM组分别为33.5%和40.9%,均明显高于NGT组(20.0%)(X^2=7.767,17.028,P均〈0.05),IGT组和T2DM组间差异无统计学意义(P〉0.05)。(5)次全或完全闭塞发生率T2DM组和IGT组分别为22.6%和18.0%,均高于NGT组(7.6%)(X^2=14.573,8.019,P均〈0.05),而IGT组和T2DM组间差异无统计学意义(P〉0.05);IGT组和T2DM组血管弥漫性病变发生率分别为24.8%和30.8%,均高于NGT组(12.4%)(X^2=8.583,16.724,P均〈0.05),但IGT组和T2DM组间差异无统计学意义(P〉0.05)。(6)Gensini评分IGT组和T2DM组分别为(55.05±22.99)和(56.15±24.87),较NGT组(38.03±17.38)明显升高,其差异有统计学意义(t=17.0142,18.1186,P均〈0.01),IGT组与T2DM组问比较差异无统计学意义(P〉0.05)。结论IGT患者2支及3支冠状动脉病变发生率明显升高,次全或完全闭塞及弥漫性病变发生率也明显高于NGT者,与糖尿病患者冠状动脉病变特点相似,提示IGT与冠状动脉病变严重程度密切相关,临床工作中应高度重视此类患者。 Objective To investigate the characteristics of coronary's pathological changes in patients with impaired glucose tolerance. Methods Four-hundred and ninety patients who were suspected with ischemic chest pain were divided into three groups according to their OGT'F results: ( 1 ) IGT group: n = 161, (2) T2DM group: n = 159, ( 3 ) NGT group: n = 170. Serum levels of triglyceride ( TG), total cholesterol ( TC ), high- density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C) and high sensitive C- reactive protein (hs-CRP) were detected, their body mass indexes (BMI)were calculated. General clinical information (including gender, age, history of smoking, history of hypertension) were collected. All the CAG results were analyzed and Gensini scores were assessed as well. Results The TG levels in the T2DM group and IGT group ( [2.41±1.70] mmol/L and [2. 26±1.20] mmoL/L) were significantly higher than that of the NGT group (1.95±1.14) mmoL/L,the differences were significant (t =0. 4610,0. 3124,P 〈0. 01 and 0. 05, respectively), whereas there was no significant difference between the IGT group and T2DM group (P 〉 0. 05 ) ; No significant difference was found among the three groups about TC, HDL-C, LDL-C levels ( either P 〉 0.05 ) ~ The levels of hs-CRP in T2DM group ( [ 2. 38±1.76 ] mg/L and IGT group [ 2. 33±2.03 ] mg/L) were higher compared with the NGT group ( [ 1.54±1.32 ] mg/L) , the differences were significant ( t = 0. 8391, 0. 7815 ,Ps 〈0. 01 ),whereas there was no significant difference between the IGT group and T2DM group (P 〉 0.05 ). BMIs of the IGT group ( [ 25.50 ~ 3.04 ] kg/m2 ) and T2DM group ( [ 26.09±2. 86 ] kg/m2 ) were higher than that of the NGT group ( [ 24.70±3.27 ] kg/m2 ), the differences were significant ( t = 0. 8063, 1. 3947 ,P 〈0. 05 and 〈 0. 01, respectively), whereas no significant difference was found between the T2DM group and IGT group (P 〉 0. 05 ). The incidence of single coronary pathological changes was 44.7% in the NGT group,it was higher than that of the IGT group (23.6%) and T2DM group ( 18.9% ) (X2 = 16. 310,25. 116, Ps 〈 0. 05 ) ,whereas there was no significant difference between the IGT group and T2DM group ( P 〉 0. 05 ) ; The incidences of 2 branches pathological changes in the T2DM group (37. 1% ) and IGT group (39. 8% ) were higher compared with NGT group (23.5%) , the differences were significant (X2 = 7. 200,10. 099 ,Ps 〈 0. 05 ) , whereas there was no significant difference between the IGT group and T2DM group( P 〉 0. 05 ) ;The incidences of 3 vessels pathological changes in the T2DM group (40.9%) and IGT group (33.5%) were higher than that of the NGT group (20. 0% ), the differences were significant ( X2 = 7. 767,17.028, Ps 〈 0. 05 ), there was no significant difference between the IGT group and T2DM group ( P 〉 0. 05 ). The incidence of subtotal or total occlusion of the T2DM group and IGT group were 22. 6% and 18. 0% respectively ,both were higher than that of the NGT group(7.6% ) ( X2 = 14. 573,8. 019 ,Ps 〈 0. 05 ), whereas no significant difference was found between the T2DM group and IGT group ( P 〉 0. 05 ). The incidences of vascular diffusing pathological change in the IGT group (24. 8% ) and T2DM group ( 30. 8% ) were higher compared with the NGT group ( 12. 4% ) ( X2 = 8. 583,16. 724, Ps 〈 0. 05 ), whereas there was no significant difference between the IGT group and T2DM group (P 〉0. 05). The Gensini scores in the IGT group (55.05 ~ 22. 99) and T2DM group(56. 15±24. 87) were significnatly higher than that of the NGT group ( 38.03 ~ 17.38 ), the differences were significant ( ( t = 17. 0142,18.1186,Ps 〈0. 01 ) ,whereas there was no significant difference between the IGT group and T2DM group (P 〉 0. 05 ). Conclusion The incidences of 2 and 3 vessels pathological changes increase significantly in patients with IGT. Moreover, the incidences of occlusion and diffuse stenosis increase significantly. This is similar to the coronary artery pathological charactersitics in patients with diabetes, which indicates that IGT is closely related to the pathological severity of coronary artery. We should pay much attention to those patients with IGT in the clinical work.
出处 《中国综合临床》 2011年第6期578-581,共4页 Clinical Medicine of China
关键词 糖耐量减低 葡萄糖耐量试验 冠状动脉 冠状动脉造影 Impaired glucose tolerance Oral glucose tolerance test Coronary artery Coronary angiography
  • 相关文献

参考文献12

  • 1Fujishima M,Kiyohara Y,Kato I,et al.Diabetes and cardiovascular disease in a prospective population survey in Japan:The Hisayama Study[J].Diabetes,1996,45(Suppl 3):S14-16.
  • 2Bartnik M,Ryden L,Ferrari R,et al.The prevalence of abnormal glucose regulation in patients with coronary artery disease across Europe.The Euro Heart Survey on diabetes and the heart[J].Eur Heart J,2004,25(21):1880-1890.
  • 3Norhammar A,Tenerz A,Nilsson C,et al.Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus:a prospective study[J].Lancet,2002,359(9324):2140-2144.
  • 4中国心脏调查组,胡大一,潘长玉.中国住院冠心病患者糖代谢异常研究——中国心脏调查[J].中华内分泌代谢杂志,2006,22(1):7-10. 被引量:470
  • 5Gensini GG.A more meaningful scoring system for determining the severity of coronary heart disease[J].Am J Cardiol,1983,51(3):606.
  • 6DECODE Study Group,the European Diabetes Epidemiology Group.Glucose tolerance and cardiovascular mortality:comparison of fasting and 2-hour diagnostic criteria[J].Arch Intern Med,2001,161(3):397-405.
  • 7Choi KM,Lee KW,Kim SG,et al.Inflammation,insulin resistance,and glucose intolerance in acute myocardial infarction patients without a previous diagnosis of diabetes mellitus[J].J Clin Endocrinol Metab,2005,90(1):175-180.
  • 8田声放,李长贵,康维强,乔树宾,松尾修三.冠心病患者冠状动脉病变与糖耐量变化的关系[J].中华内分泌代谢杂志,2002,18(4):289-292. 被引量:38
  • 9Kataoka Y,Yasuda S,Morii I,et al.Quantitative coronary angiographic studies of patients with angina pectoris and impaired glucose tolerance[J].Diabetes Care,2005,28(9):2217-2222.
  • 10Karasik A.Glycaemic control is essential for effective cardiovascular risk reduction across the type 2 diabetes continuum[J].Ann Med,2005,37(4):250-258.

二级参考文献33

  • 1江时森,黄浙勇.危险因素的评估在冠心病临床诊断中的参考价值研究[J].心肺血管病杂志,2006,25(1):5-7. 被引量:12
  • 2李素青,田玉华,朱敏,杨超元.中老年糖尿病流行病学调查方法探讨[J].实用老年医学,1996,10(4):175-176. 被引量:13
  • 3Tai ES, Gob SY, Lee JJ, et al. Lowering the criterion for impaired fasting glucose: impact on disease p revalence and associated risk of diabetes and ischemic heart disease. Diabetes Care, 2004, 27: 1728-1734.
  • 4The DECODE study group on behalf of the european diabetesEp idemiology group, glucose tolerance and cardiovascular mortality. Arch IntMed,2001,161 : 397-404.
  • 5Bartnik M, Ryden L, Ferrari R, et al. The prevalence of abnormalglucose regulation in patients with coronary artery disease across Europe: the Euro Heart Survey on diabetes and the heart. Eur Heart J,2004, 25: 1880-1890.
  • 6Choi KM, Lee KW, Kim SG, et al. Inflammation, insulin resistance, and glucose in tolerance in acute myocardial infarction patients without a p revious diagnosis of diabetesmellitus. J Clin EndocrinolMetab, 2005,90: 175- 180.
  • 7Henry P. Increased incidence of moderate stenosis among patients with diabetes: substrate formyocardial infarction. Heart J, 1997,134 : 1037- 1047.
  • 8Expert Panel on Detection. Evaluation, and Treatment of High Blood Cholesterol in Adults.. JA MA,2001,285:2486- 2497.
  • 9Capes SE, Hunt D, Malmberg K, et al. St ress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet, 2000,355 : 773-778.
  • 10刘群,赵冬,王薇.冠心病二级预防实施研究进展[J].心肺血管病杂志,2007,26(3):190-192. 被引量:24

共引文献516

同被引文献44

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部